Related Experiment Videos
A new two-dimensional echocardiographic technique for evaluating right ventricular size and performance in patients
Circulation
|September 1, 1982
Summary
Two-dimensional echocardiography accurately assesses right ventricular size and function in COPD patients, comparing well with radionuclide angiography both at rest and after nitrate administration.
Area of Science:
- Cardiology
- Pulmonology
- Medical Imaging
Background:
- Chronic obstructive pulmonary disease (COPD) often affects right ventricular (RV) function.
- Accurate assessment of RV size and performance is crucial for managing COPD patients.
- Two-dimensional echocardiography (2-D echo) and radionuclide angiography (RNA) are methods for evaluating RV function.
Purpose of the Study:
- To compare 2-D echocardiographic estimates of RV size and performance with RNA.
- To evaluate the effects of isosorbide dinitrate on RV parameters measured by both methods.
- To determine the feasibility of 2-D echo for RV assessment in severe COPD patients.
Main Methods:
- 19 patients with severe COPD were evaluated.
- RV end-diastolic volume, end-systolic volume, and ejection fraction (EF) were measured using 2-D echo and RNA.
- Measurements were taken at rest and after isosorbide dinitrate administration.
Main Results:
- 2-D echo RV volumes and EF correlated well with RNA measurements (r=0.76-0.82 for volumes, r=0.80 for EF).
- Isosorbide dinitrate significantly decreased RV volumes and systolic arterial pressure, and increased heart rate, but did not significantly alter RV EF by either method.
- Correlations between 2-D echo and RNA remained strong after nitrate administration (r=0.75-0.79).
Conclusions:
- 2-D echocardiography is a feasible method for assessing RV size and performance in selected COPD patients.
- 2-D echo measurements of RV size and function compare favorably with RNA.
- These findings support the use of 2-D echo for RV evaluation in COPD patients at rest and after nitrate administration.